Contract 75N96020F00065
Life Technologies Corporation · Department Of Health And Human Services · June 2, 2020
Life Technologies Corporation was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on June 2, 2020 for $100,000 of work in biological product (except diagnostic) manufacturing. Performance is in Carlsbad, CA. This is a task or delivery order issued under parent IDIQ 75N96020D00011. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 1, 2022.
Contract details
- PIID
- 75N96020F00065
- Parent IDIQ
- 75N96020D00011
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Carlsbad, CA
- First action
- June 2, 2020
- Latest action
- September 1, 2022
Description
LIFE TECHNOLOGIES CORPORATION:1107072 [20-007699]
Modification timeline
-
September 1, 2022Mod P00001$-10
-
June 2, 2020Base award$100.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N96020F00065?
Contract 75N96020F00065 is a federal contract awarded to Life Technologies Corporation by Department Of Health And Human Services on June 2, 2020 for $100,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75N96020F00065?
Life Technologies Corporation won contract 75N96020F00065 from Department Of Health And Human Services.
How much is contract 75N96020F00065 worth?
Contract 75N96020F00065 has obligated $100,000 to date.